Azole resistance in neonatal intensive care units in Argentina

Journal of Chemotherapy

Volumn 17, Issue 3, 2005, Pages 347-350

  Giusiano, Gustavo E ^a   Mangiaterra, M ^a   Rojas, F ^a   Gomez, V ^a  

^a UNIVERSIDAD NACIONAL DEL NORDESTE   (Argentina)

Author keywords

Candida; Fluconazole; Itraconazole; Neonates; Resistance

Indexed keywords

FLUCONAZOLE; ITRACONAZOLE; PYRROLE;

ANTIBIOTIC SENSITIVITY; ARGENTINA; ARTICLE; BLADDER ASPIRATION; BLOOD FLOW; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA TROPICALIS; CANDIDIASIS; CROSS RESISTANCE; FUNGUS ISOLATION; HUMAN; INTRAVENOUS CATHETER; MINIMUM INHIBITORY CONCENTRATION; MYCOSIS; NEWBORN; NEWBORN INTENSIVE CARE; NONHUMAN; RECTUM; YEAST;

EID: 22244434650     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2005.17.3.347     Document Type: Article

References (30)

1. Berrouane YF, Herwaldt LA, Pfaller MA. Trend in antifungal use and epidemiology of nosocomial yeast infections in a university Hospital. J Clin Microbiol 1999; 37: 531-537.
2. Abi-Said D, Anaissie E, Uzun O, Raad I, Pinzcowski H, Vartivarian S. The epidemiology of hematogenous candidiasis caused by different Candida species. Clin Infect Dis 1997; 24: 1122-1128.
3. Arévalo MP, Carrillo-Muñoz AJ, Salgado J et al. Antifungal activity of the echinocandin anidulafungin (VER002,LY-303366) against yeast pathogens: a comparative study with M27-A microdilution method. J Antimicrobial Chemother 2003; 51: 163-166.
4. Pfaller MA, Jones RN, Doern GV et al. International surveillance of bloodstream infections due to Candida Species: frequency of occurrence and antifungal susceptibilities of isolates collected in 1997 in the United States, Canada, and South America for the SENTRY Program. J Clin Microbiol 1998; 36: 1886-1889.
5. Pfaller MA, Jones RN, Doern GV et all. Bloodstream infections due to Candida species: SENTRY antimicrobial surveillance program in North America and Latin America, 1997-1998. Antimicrob Agents Chemother 2000; 44: 747-751.
6. Rennert G, Rennert HS, Pitlik S, Finkelstein R, Kitzes-Cohen R. Epidemiology of candidemia - a nationwide survey in Israel. Infection 2000; 28: 26-29.
7. Singh K, Chakrabarti A, Narang A, Gopalan S. Yeast colonization & fungaemia in preterm neonates in a tertiary care center. Indian J Med Res 1999; 110: 169-173.
8. Levy I, Rubin LG, Vasishtha S, Tucci V, Sood SK. Emergence of Candida parapsilosis as the predominant species causing candidemia in children. Clin Infect Dis 1998; 26: 1086-1088.
9. Kao AS, Brandt ME, Pruitt WR et al. The epidemiology of candidemia in two United States cities: results of a population-based active surveillance. Clin Infect Dis 1999; 29: 1164-1170.
10. Rangel-Frausto MS, Wiblin T, Blumberg HM et al. National epidemiology of mycoses survey (NEMIS): variation rates of bloodstream infection due to Candida species in several surgical intensive care units and six neonatal intensive care units. Clin Infect Dis 1999; 29, 253-258.
11. Rey W, eds. Atlas total de la Republica Argentina. Provincia de Corrientes. Buenos Aires. Centro editor de America Latina, 1992: 76-79.
12. Negroni R, Guelfand L. Manual de procedimientos para laboratorios de Micología Médica. 1st ed. Acta Bioquímica Clínica Latinoamericana. Buenos Aires. 1999.
13. Maki DG, Weise CE, Sarafin HW. A semicuantitative culture method for identifying intravenous catheter-related infection. New Engl J Med 1977; 296: 1305-1309.
14. Cleri DJ, Corrado ML, Seligman SJ. Quantitative culture of intravenous catheter and other intravascular inserts. J Infect Dis 1980; 141: 781-786.
15. Kreeger-Van Rij NJ. W. The Yeasts: a taxonimic study. Amsterdam. Elsevier Science Publishers. 1984: 47-103.
16. Guillot J, Guého E, Lesourd M, Midgley G, Chévrier G, Dupont B. Identification of Malassez ia species. A practical approach. J Mycol Med 1996; 6: 103-110.
17. National Committee for Clinical Laboratory Standards. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts. Approved Standard. M27-A. Wayne, Pennsylvania. 1997.
18. Rex JH, Pfaller MA, Galgiani JN et al. Development of interpretative breakpoints for antifungal susceptibility testing: Conceptual framework and analysis of in vitro-in vivo correlation data for fluconazol, itraconazole and Candida infections. Clin Infect Dis 1997; 24: 235-475
19. Saiman L, Ludington E, Pfaller M et al. Risk factors for candidemia in Neonatal Intensive care Units patients. The National Epidemiology of Mycosis Survey study group. Pediatr Infect Dis J 2000; 19: 319-324.
20. Pfaller MA, Messer SA, Hollis RJ et al. Trends in species distribution and susceptibility to fluconazole among blood stream isolates of Candida species in the United States. Diagn Microbiol Infect Dis 1999; 33: 217-222.
21. Odds FC. Resistance of clinically important yeasts to antifungal agents. Int J Antimicrob Agents 1996; 6: 145-147.
22. Sanglard D, Odds F. Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences. Lancet 2002; 2: 73-85.
23. Wingard JR, Merz WG, Rinaldi MG, Johnson TR, Karp JE, Saral R. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N Engl J Med 1991; 325: 1274-1277.
24. Rodero L, Boutureira M, Demkura H et al. Infecciones por levaduras: agentes causales y su resistencia a antifúngicos en pacientes pediátricos hospitalizados y en adultos HIV positivos. Rev Arg Microbiol 1997; 29: 7-15.
25. Fairchild KD, Tomkoria S, Sharp EC, Mena FV. Neonatal Candida glabrata sepsis: clinical and laboratory features compared with other Candida species. Pediatr Infect Dis J 2002; 21: 39-43.
26. Dutta S, Narang A. Drug resistant neonatal Candida tropicalis septicemia. Did it cause diaphragmatic hernia? Indian Pediatr 2003; 40: 261-264.
27. Saiman L, Ludington E, Dawson J et al. Risk factors for Candida species colonization of neonatal intensive care units patients. Pediatr Infect Dis J 2001; 20: 1119-1124.
28. Mac Donald L, Baker C, Chenoweth C. Risk factors for candidemia in a children's hospital. Clin Infect Dis 1998; 26: 642-645.
29. Rodero L, Davel G, Córdoba S et al. Estudio multicéntrico sobre candidiasis nosocomial en la República Argentina. Rev Arg Microbiol 1999; 31: 114-119.
30. Huang YC, Kao HT, Lin TY, Kuo AJ. Antifungal susceptibility and the correlation with clinical outcome in neonatal candidemia. Am J Perinatol 2001; 18, 141-146.